LIPOSCIENCE INC 4
4 · LIPOSCIENCE INC · Filed Jan 30, 2013
Insider Transaction Report
Form 4
LIPOSCIENCE INCLPDX
SANDERS CHARLES A
Director
Transactions
- Conversion
Series E Convertible Preferred Stock
2013-01-30−2,298→ 0 total→ Common Stock (1,114 underlying) - Conversion
Common Stock
2013-01-30+1,114→ 9,844 total
Footnotes (3)
- [F1]Represents shares received upon conversion of shares of Series E convertible preferred stock.
- [F2]Effective immediately prior to the closing of the issuer's initial public offering of its common stock, each share of Series E convertible preferred stock automatically converted into 0.485 shares of common stock. The convertible preferred stock had no expiration date.
- [F3]The Series E Convertible Preferred Stock converted into common stock on a 0.485-for-1 basis and had no expiration date.